High circulating D-dimers are associated with ascites and hepatocellular carcinoma in liver cirrhosis

World Journal of Gastroenterology

Volumn 14, Issue 10, 2008, Pages 1549-1552

  Spadaro, Aldo ^a   Tortorella, Vincenza ^a   Morace, Carmela ^a   Fortiguerra, Agostino ^a   Composto, Paola ^a   Bonfiglio, Caterina ^a   Alibrandi, Angela ^b   Luigiano, Carmelo ^a   De Caro, Giuseppe ^a   Ajello, Antonino ^a   Ferraù, Oscar ^a   Freni, Maria Antonietta ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Ascites; D dimers; Hepatocellular carcinoma; Hyperfibrinolysis; Liver cirrhosis

Indexed keywords

D DIMER; DIURETIC AGENT;

ADULT; AGED; ARTICLE; ASCITES; CONTROLLED STUDY; DISEASE MARKER; ECHOGRAPHY; FEMALE; FIBRINOLYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PARACENTESIS; PROTEIN BLOOD LEVEL; REMISSION; SODIUM RESTRICTION; TURBIDIMETRY;

EID: 41549152950     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.1549     Document Type: Article

References (13)

1. Agarwal S, Joyner KA Jr, Swaim MW. Ascites fluid as a possible origin for hyperfibrinolysis in advanced liver disease. Am J Gastroenterol 2000; 95: 3218-3224
2. Pesarin F. Non Parametric Combination Methodology. In: Pesarin F. Multivariate permutation tests: with application in biostatistics. Chichester, New York, Weinheim, Brisbane, Singapore, Toronto: John Wiley & Sons, 2001: 133-163
3. Fahrmeir L, Tutz G. Survival models. In: Fahrmeir L, Tutz G. Multivariate statistical modelling based on generalized linear models. 2nd ed. New York: Springer, 2001: 385-429
4. Che PY, Popovich PM. Correlation: parametric and non-parametric measures. Newbury Park, CA: Sage University Paper, 2002: 95-97
5. Kleimbaum DG. Introduction to logistic regression. In: Kleimbaum DG. Logistic regression. New York: Springer-Verlag, 1994: 2-37
6. Kang Y, Lewis JH, Navalgund A, Russell MW, Bontempo FA, Niren LS, Starzl TE. Epsion-aminocaproic acid for treatment of fibrinolysis during liver transplantation. Anesthesiology 1987; 66: 766-773
7. Porte RJ, Bontempo FA, Knot EA, Lewis JH, Kang YG, Starzl TE. Systemic effects of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation. Transplantation 1989; 47: 978-984
8. Steib A, Gengenwin N, Freys G, Boudjema K, Levy S, Otteni JC. Predictive factors of hyperfibrinolytic activity during liver transplantation in cirrhotic patients. Br J Anaesth 1994; 73: 645-648
9. Hu KQ, Yu AS, Tiyyagura L, Redeker AG, Reynolds TB. Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit. Am J Gastroenterol 2001; 96: 1581-1586
10. Kim HK, Lee KR, Yang JH, Yoo SJ, Lee SW, Jang HJ, Park SJ, Moon YS, Park JW, Kim CM. Plasma levels of D-dimer and soluble fibrin polymer in patients with hepatocellular carcinoma: a possible predictor of tumor thrombosis. Thromb Res 2003; 109: 125-129
11. Toschi V, Rocchini GM, Motta A, Fiorini GF, Cimminiello C, Violi F, Castelli C, Sironi D, Gibelli A. The hyperfibrinolytic state of liver cirrhosis: possible pathogenetic role of ascites. Biomed Pharmacother 1993; 47: 345-352
12. Violi F, Ferro D, Basili S, Quintarelli C, Musca A, Cordova C, Balsano F. Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis. The CALC Group. Coagulation Abnormalities in Liver Cirrhosis. Hepatology 1993; 17: 78-83
13. Piscaglia F, Donati G, Giannini R, Bolondi L. Liver cirrhosis, ascites, and hyperfibrinolysis. Am J Gastroenterol 2001; 96: 3222